First Authors : Muserref Kasap Cuceoglu and Dr Tanja Hinze Journal : VRheumatology, Volume 65, Issue 5 Date : May 2026 Article link : https://doi.org/10.1093/rheumatology/keag230 Cross-national access to IL-1 inhibitors in FMF Can patients with colchicine-resistant FMF access IL-1 inhibitors equally, regardless of where they live? A new study from the JIR-CliPS project compared national guidelines, availability and reimbursement policies for IL-1 inhibitors in FMF across 39 c

May 12th to June 6th, 2025 – Lausanne, Switzerland In May/June 2025, the international JIR-CliPS project under the COST Action CA21168...

During the JIR Winter School 2024 in Switzerland, Dr. Tillmann Kallinich from Germany and Dr. Yonatan Butbul from Israel discussed the...

As the second year of our Short Term Scientific Mission (STSM) program has ended, it's time to reflect on another incredible journey of...

The article "Breaking down the fences among registries on autoinflammatory diseases: the E-Merge project" written by Yulia Vyzhga, Marco...

The JIR CliPS project marked a significant milestone in its first year by welcoming ten young physicians (2 per Working Group), for a...

Summary of our first face to face meeting in Chateau d'Oex Switzerland. 35 worldwide physicians experts in the field of rheumatology went...

1. Definition of Serum Amyloid A Under certain circumstances like inflammation or infections, cytokines are produced (like IL1 and IL6)....